IRIS
MILANA, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.716
EU - Europa 215
AS - Asia 191
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 2.126
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.711
SG - Singapore 135
IE - Irlanda 65
IT - Italia 41
RU - Federazione Russa 30
CN - Cina 28
DE - Germania 25
GB - Regno Unito 25
KR - Corea 15
CZ - Repubblica Ceca 6
BE - Belgio 5
CA - Canada 5
UA - Ucraina 5
FI - Finlandia 4
SE - Svezia 4
TM - Turkmenistan 4
CH - Svizzera 3
JP - Giappone 3
IN - India 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
EU - Europa 1
FR - Francia 1
LT - Lituania 1
MY - Malesia 1
TW - Taiwan 1
Totale 2.126
Salva come PNG Salva come JPEG
Città #
Wilmington 410
Houston 332
Chandler 171
Singapore 126
Woodbridge 121
Fairfield 93
Ashburn 85
Dublin 56
Medford 49
New York 36
Seattle 33
Cambridge 29
Ann Arbor 24
Rome 23
Santa Clara 23
Lawrence 22
San Diego 17
Beijing 16
Seoul 14
Munich 12
Washington 12
Menlo Park 11
Creede 8
London 7
Palo Alto 7
Brussels 5
Miami 5
Toronto 5
Dearborn 4
Bloomfield 3
Brno 3
Colorado Springs 3
Hounslow 3
Moscow 3
Bagnoregio 2
Engelhard 2
Esslingen am Neckar 2
Fremont 2
Hangzhou 2
Helsinki 2
Jacksonville 2
Kilburn 2
Kunming 2
Lahore 2
Norwalk 2
Nuremberg 2
Olomouc 2
The Dalles 2
Zurich 2
Adliswil 1
Boardman 1
Canberra 1
Chieti 1
Chiswick 1
Council Bluffs 1
Falls Church 1
Frankfurt am Main 1
Fuyang 1
Gunzenhausen 1
Invorio 1
Kuala Lumpur 1
Lappeenranta 1
Leawood 1
Los Angeles 1
Magenta 1
Monmouth Junction 1
Mumbai 1
Nanjing 1
Petriolo 1
Qingdao 1
Radeberg 1
Redwood City 1
Rochester 1
San Mateo 1
Shanghai 1
Southwark 1
São Paulo 1
Taipei 1
Tower Hamlets 1
Wandsworth 1
Xi'an 1
Zhengzhou 1
Totale 1.834
Salva come PNG Salva come JPEG
Nome #
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 414
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 184
Domino liver transplantation: Where are we now? 157
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 150
The evolving scenario of HBV infection and disease: A never-ending story 147
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 142
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study 120
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 83
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 72
Natremia and liver transplantation: The right amount of salt for a good recipe 68
Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance 67
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b 61
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 55
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment? 48
Gastrointestinal endoscopy in cirrhotic patient: Issues on the table 47
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 47
COVID-19 in normal, diseased and transplanted liver 43
Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development 43
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage 39
Chronic rejection after liver transplantation: Opening the Pandora's box 38
Moving forward in the treatment of cholangiocarcinoma 37
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 34
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 29
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 27
Use of intravascular ultrasound to improve diagnosis and treatment of transjugular intrahepatic portosystemic shunt dysfunction in patients in the long-term follow-up 26
Secondary bile acids and the biliary epithelia: The good and the bad 23
null 22
Sequence of events leading to primary biliary cholangitis 12
Sarco-Model: a score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 1
Totale 2.236
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.414
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020264 0 0 0 0 8 10 8 5 44 75 58 56
2020/2021616 64 60 51 57 57 97 104 73 13 23 12 5
2021/2022305 11 38 12 8 7 33 27 17 37 27 16 72
2022/2023369 34 46 19 36 45 66 33 29 28 11 14 8
2023/2024200 17 4 25 6 38 81 2 2 6 3 2 14
2024/2025293 27 125 85 49 7 0 0 0 0 0 0 0
Totale 2.236